← Eichor
Condition: Tetanus Diphtheria Acellular Pertussis Tdap Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Tetanus Diphtheria Acellular Pertussis Tdap

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Enhancing Maternal Vaccine Knowledge and Uptake: The InTroDuce-Programme Trial
NA · 4 location(s) · Universiti Putra Malaysia · NCT06815250
Immunogenicity and Safety of Diphtheria, Tetanus, Pertussis (DTaP) Vaccine in 3-month-old Infants
Phase 3 · 1 location(s) · Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd · NCT06344065
A Phase I/II Study to Evaluate the Safety and Immunogenicity of GC3111B in Healthy Adults
Phase 1/Phase 2 · 1 location(s) · GC Biopharma Corp · NCT06997627
Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135
Phase 1 · 1 location(s) · CanSino Biologics Inc. · NCT07203755
Concurrent Versus Sequential Administration of Tdap and RSV Vaccines in Pregnancy
Phase 4 · 4 location(s) · Canadian Immunization Research Network · NCT07097012
Assessing Interventions to Increase Tdap Acceptance for Non-birthing Partners in Pregnancy
Phase 4 · 1 location(s) · Women and Infants Hospital of Rhode Island · NCT06135636
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.